Molecular basis for the treatment of achondroplasia.

Yamanaka, Yoshitaka; Ueda, Koso; Seino, Yoshiki; Tanaka, Hiroyuki

Yamanaka, Yoshitaka; Ueda, Koso; Seino, Yoshiki; Tanaka, Hiroyuki.

Affiliation

Yamanaka Y; Department of Pediatrics, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan. yamanaka@cc.okayama-u.ac.jp

Horm Res ; 60 Suppl 3: 60-4, 2003.

Article in En | MEDLINE | ID: mdl-14671399

Subject(s)

Achondroplasia/drug therapy; Achondroplasia/genetics; Protein-Tyrosine Kinases/genetics; Protein-Tyrosine Kinases/metabolism; Receptors, Fibroblast Growth Factor/genetics; Receptors, Fibroblast Growth Factor/metabolism; Achondroplasia/metabolism; Achondroplasia/pathology; Animals; Apoptosis/genetics; Cell Line; Chondrocytes/cytology; Chondrocytes/metabolism; Humans; Insulin-Like Growth Factor I/pharmacology; MAP Kinase Signaling System/drug effects; Mice; Mutation; Parathyroid Hormone-Related Protein/metabolism; Parathyroid Hormone-Related Protein/pharmacology; Phosphatidylinositol 3-Kinases/metabolism; Receptor, Fibroblast Growth Factor, Type 3

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Achondroplasia / Protein-Tyrosine Kinases / Receptors, Fibroblast Growth Factor Limits: Animals / Humans Language: En Journal: Horm Res Year: 2003 Document type: Article Affiliation country: Japan Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links